{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.03, "exchange": "FRA", "shortName": "ALBERT LABS INTL. CORP.", "longName": "Albert Labs International Corp.", "messageBoardId": "finmb_700386261", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketTime": 1683699068, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.221, "sharesOutstanding": 68163296, "bookValue": 0.003, "fiftyDayAverage": 0.03438, "fiftyDayAverageChange": -0.0043800008, "fiftyDayAverageChangePercent": -0.12739967, "twoHundredDayAverage": 0.0413825, "twoHundredDayAverageChange": -0.0113825, "twoHundredDayAverageChangePercent": -0.2750559, "marketCap": 2292105, "priceToBook": 10.0, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1648620000000, "priceHint": 4, "regularMarketChange": 0.0, "regularMarketDayHigh": 0.03, "regularMarketDayRange": "0.03 - 0.03", "regularMarketDayLow": 0.03, "regularMarketVolume": 19800, "regularMarketPreviousClose": 0.03, "bid": 0.0, "ask": 0.0, "fullExchangeName": "Frankfurt", "financialCurrency": "CAD", "regularMarketOpen": 0.03, "averageDailyVolume3Month": 649, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.016999999, "fiftyTwoWeekLowChangePercent": 1.3076922, "fiftyTwoWeekRange": "0.013 - 0.222", "fiftyTwoWeekHighChange": -0.192, "fiftyTwoWeekHighChangePercent": -0.8648649, "fiftyTwoWeekLow": 0.013, "fiftyTwoWeekHigh": 0.222, "symbol": "VB50.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "6996 Merritt Avenue", "address2": "Suite 201", "city": "Burnaby", "state": "BC", "zip": "V5J 4R6", "country": "Canada", "website": "https://albertlabs.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Albert Labs International Corp. operates as a clinical research and drug development company. The company focuses on treating patients with urgent and unmet needs, including critical mental health indications. It develops psilocybin-assisted therapies to improve mental health conditions, including anxiety, depression, and oncology-related distress. The company is based in Burnaby, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Michael E. D.  Raymont B.Sc (Hons)., Ph.D.", "age": 73, "title": "CEO & Chairman", "yearBorn": 1949, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Navchand  Jagpal", "age": 54, "title": "CFO & Director", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Santoke  Naal", "title": "Chief Operating Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Toby  Sorabjee", "title": "Chief Communications Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Malcolm  Barratt-Johnson", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ali  Gulamhusein", "title": "Chief Devel. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}